Published in Vaccine Weekly, October 9th, 1995
CD8+ cytotoxic T lymphocytes (CTL) are an important component in the immunologic control of human viral disease. IL-7, a stromal cell-derived cytokine, has been demonstrated to enhance both anti-tumor and anti-viral CTL as well as lymphokine-activated killer (LAK) activity.
In this study researcher G. Ferrari examined the ability of IL-7 to support the activation and the growth of in vitro antigen-specific CTL precursors (CTLp)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly